Pain News and Research

Latest Pain News and Research

Study examines regional analgesia effect on long-term outcomes in soldiers with combat injuries

Little is known about the impact of early aggressive regional analgesia on short- and long-term pain and psychological outcomes of soldiers with major combat injuries.

25 Mar 2011

HCG hormone therapy may benefit patients with intractable pain

Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented at a poster session at the American Academy of Pain Medicine's 27th Annual Meeting.

25 Mar 2011

$ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro$

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs.

25 Mar 2011

New platinum coil technology makes minimally invasive surgery for brain aneurysms safer and cheaper

Loyola University Hospital is the first center in the Midwest to use new technology that makes minimally invasive surgery for life-threatening brain aneurysms significantly safer and cheaper.

25 Mar 2011

AAE wants to dispel negative myths about root canal treatment

When it comes to their teeth, Americans have strong feelings about keeping them. According to a January 2011 survey by the American Association of Endodontists, 70 percent of Americans want to avoid losing their natural teeth.

25 Mar 2011

New findings may make morphine a safer, more effective drug for chronic pain control

An orphan drug originally used for HIV treatment has been found to short-circuit the process that results in additional sensitivity and pain from opioid use. The study by researchers at the Indiana University School of Medicine is reported in the March 25, 2011 issue of Brain, Behavior and Immunity.

25 Mar 2011

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor features an innovative locking system designed to improve lead anchoring speed and consistency.

25 Mar 2011

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.

25 Mar 2011

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

AlphaRx Inc. has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.

25 Mar 2011

Study: Surgeon enthusiasm linked to high spinal procedure rates

Surgeons in some areas are more likely to recommend surgery for low back problems—and those differences in "surgeon enthusiasm" are a major factor driving regional variations in spinal surgery rates, suggests a study in the March 14 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Mar 2011

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

AltheRx Inc., a privately-held clinical development company, announced today that it has purchased all assets related to Solabegron from GlaxoSmithKline. Solabegron is a highly selective and potent beta3-adrenoceptor agonist that has demonstrated positive results in Phase II clinical programs for the treatment of Overactive Bladder in women and Irritable Bowel Syndrome.

25 Mar 2011

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

The Food and Drug Administration today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

25 Mar 2011

Food safety lawyer calls on Palmyra to pay medical expenses incurred by E. coli outbreak victims

Food safety lawyer Fred Pritzker is calling on Palmyra Bologna Company, Inc., maker of Seltzer's Lebanon bologna products, to pay medical expenses and other costs incurred by victims of a multistate E. coli O157:H7 outbreak in New Jersey, North Carolina and Pennsylvania.

24 Mar 2011

Little evidence supporting effectiveness of acupuncture in reducing pain

Although acupuncture is commonly used for pain control, doubts about its effectiveness and safety remain. Investigators from the Universities of Exeter & Plymouth (Exeter, UK) and the Korea Institute of Oriental Medicine (Daejeon, South Korea) critically evaluated systematic reviews of acupuncture as a treatment of pain in order to explore this question.

24 Mar 2011

House bill proposes immunity for negligent drug manufacturers

Rep. Johnathan Rhyne, Republican Chairman of the NC House Select Committee on Tort Reform, today launched an assault on patients rights, adding provisions to favor insurance companies and drug manufacturers to a controversial Senate bill.

24 Mar 2011

Tick-borne disease identified as emerging threat

Five years ago, large numbers of farmers in central China began falling victim to an mysterious disease marked by high fever, gastrointestinal disorder and an appalling mortality rate - as high as 30 percent in initial reports. Investigators from the Chinese Center for Disease Control and Prevention hurried to the scene of the outbreak. On the basis of DNA evidence, they quickly concluded that it had been caused by human granulocytic anaplasmosis, a bacteria transmitted by tick bites.

24 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

Positive data from Omeros' OMS302 Phase 2b trial in patients undergoing cataract surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.

23 Mar 2011

Xenon founder receives Canada Wightman Award for leadership in medical science

Dr. Michael Hayden, a Xenon founder and Chief Scientific Officer, has received the Canada Gairdner Wightman Award for leadership in medical science in Canada.

23 Mar 2011

$Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty$

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.

23 Mar 2011

Pain News and Research

Latest Pain News and Research

Study examines regional analgesia effect on long-term outcomes in soldiers with combat injuries

HCG hormone therapy may benefit patients with intractable pain

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

New platinum coil technology makes minimally invasive surgery for brain aneurysms safer and cheaper

AAE wants to dispel negative myths about root canal treatment

New findings may make morphine a safer, more effective drug for chronic pain control

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

Study: Surgeon enthusiasm linked to high spinal procedure rates

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

Food safety lawyer calls on Palmyra to pay medical expenses incurred by E. coli outbreak victims

Little evidence supporting effectiveness of acupuncture in reducing pain

House bill proposes immunity for negligent drug manufacturers

Tick-borne disease identified as emerging threat

Cilag, POZEN enter license agreement to develop and commercialize MT 400

Positive data from Omeros' OMS302 Phase 2b trial in patients undergoing cataract surgery

Xenon founder receives Canada Wightman Award for leadership in medical science

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in